Few doctors have seen it before

Mission Hospital’s Measles Exposure: A Warning Sign for U.S. Healthcare? A recent measles exposure at Mission Hospital in Asheville, North Carolina, has brought into sharp focus a growing concern: the increasing risk of encountering measles and a potential decline in healthcare professionals’ ability to quickly identify the virus. The incident, which led to the hospital … Read more

Russian-run Texas medical supplier at center of massive Medicare billing scheme, feds say

Medicare Fraud Scheme: A $3.4 Billion Wake-Up Call A small Austin, Texas medical supply business, Centurion Superior Medical, has become the focal point of a massive Medicare billing scheme, raising serious questions about vulnerabilities in the U.S. Healthcare system. Federal prosecutors allege the company, along with a Florida-based counterpart, fraudulently billed Medicare for billions of … Read more

Air pollution linked to higher risk of developing Alzheimer’s disease

Air Pollution and Alzheimer’s: A Growing Concern for Brain Health Latest research indicates a significant link between long-term exposure to air pollution and an increased risk of Alzheimer’s disease. A study led by Yanling Deng of Emory University, published February 17th, analyzed data from over 27.8 million U.S. Medicare recipients aged 65 and older between … Read more

What our teeth reveal about the growing gap between rich and poor

The Silent Epidemic: How Dental Health Reveals Growing Inequality Teeth are more than just tools for eating; they’re increasingly visible markers of socioeconomic disparity. The gap between those who can afford pristine, cosmetically enhanced smiles and those struggling with “poor teeth,” as US journalist Sarah Smarsh terms it, is widening. This isn’t simply a cosmetic … Read more

Medicare coverage of Ozempic could change weight loss treatment options—CEO

The Weight Loss Revolution: How Medicare Coverage is Reshaping the Future of Obesity Treatment The landscape of weight loss treatment is undergoing a dramatic shift. Recent decisions regarding Medicare coverage for GLP-1 medications like Ozempic and Wegovy, coupled with the impending launch of Eli Lilly’s new obesity pill, orforglipron, are poised to significantly impact millions … Read more

Trump Adds Physician-Administered Drugs to Medicare Price Negotiation List

Medicare Drug Price Negotiation: A Turning Tide for Healthcare Costs? The recent announcement by the Trump administration – adding 15 drugs to the Medicare price negotiation list, crucially including those administered in doctor’s offices – marks a significant shift in the landscape of pharmaceutical pricing. While framed by the administration as building on voluntary agreements, … Read more

Trump Admin Cuts Medicare Advantage Payments, Sending Insurer Stocks Down

Medicare Advantage Faces a Reality Check: What Lower Payments Mean for Your Healthcare The future of Medicare Advantage, the popular alternative to traditional Medicare, is facing a significant shift. Recent announcements from the Trump administration signal a slowdown in payment increases, sparking concern among insurers and potentially impacting beneficiaries. This isn’t just about Wall Street … Read more

Rady Children’s Health to stop transgender care amid Trump administration threats

California Pediatric Hospitals Pause Gender-Affirming Care: A Sign of Things to Come? The recent decision by Rady Children’s Health, encompassing major California pediatric facilities, to halt gender-affirming care for transgender youth marks a pivotal moment. This isn’t an isolated incident; it’s a ripple effect of escalating federal scrutiny and proposed rule changes impacting access to … Read more

Oz, Trump Officials Face Unease as Healthcare Industry Braces for $1 Trillion Medicaid Cuts

The Looming Medicaid Cliff and the Future of Healthcare Finance The scene at a San Francisco yacht club – a gathering of healthcare titans alongside figures like Mehmet Oz – underscores a critical, and increasingly anxious, moment for the industry. While the setting might suggest celebration, the underlying reality is a looming financial reckoning driven … Read more

Research finds persistent prescribing of risky medications to older adults with dementia

One in Four Seniors with Dementia Receive Risky Brain Medications: What’s Next? A concerning new study published in JAMA reveals that despite long-standing warnings, approximately 25% of Medicare beneficiaries diagnosed with dementia are still prescribed medications with potentially dangerous side effects – including increased risk of falls, confusion, and hospitalization. While prescriptions have modestly declined … Read more